Cardiofront Logo
Jafib Logo
St. Jude Medical

July 22nd, 2014
Submit Manuscript
AF Literature Database
Search Knowledgebase by
Author Last name starts with
B. Weijs(4)Ayman A. Hussein, MD(3)Asirvatham Samuel J SJ(3)
Alan S. Go, MD(3)Charlotte Eitel, MD(3)Antonio Hernández-Madrid(2)
Christian Sohns(2)Bengt Zöller(2)Badger Troy J TJ(2)
Charlotte Eitel(2)Blanke Philipp P(2)Anné Wim W(2)
Chamberlain AM(2)Berenfeld Omer O(2)Caputo M(2)
Chao TF(2)Chen Peng-Sheng PS(2)Andrade JG(2)
Akira Fukui, MD(2)Albert Nancy M NM(2)Ajay K Jain(2)
Cook G Elliott GE(2)Botto GL(2)Bokeriia L A LA(2)
Casella M(2)Belluzzi Fabio F(1)Cho In Jeong IJ(1)
Bacal F F(1)Christiansen Christine Benn CB(1)Antzelevitch Charles C(1)
Bikou O(1)Bart Maesen, MD(1)Body Simon C SC(1)
Chikwe Joanna J(1)Bevilacqua Stefano S(1)Casaclang-Verzosa Grace G(1)
Bussey Henry H(1)Chou Che-Yi CY(1)Aistrup GL(1)
Chern-En Chiang(1)Brembilla-Perrot B B(1)Abed Amr Al AA(1)
Arribas Fernando F(1)Altmann David R DR(1)Alboni Paolo P(1)
Christopher McGann, MD(1)Coralie Blanche(1)Ambăruş V V(1)
Alves Cyrielle C(1)Augello Giuseppe G(1)
Literature Related to Edvardsson NG [Author]
[1]
Does treatment with n-3 polyunsaturated fatty acids prevent atrial fibrillation after open heart surgery?
Authors : Heidarsdottir Ragnhildur R; Arnar David O DO; Skuladottir Gudrun V GV; Torfason Bjarni B; Edvardsson Vidar V; Gottskalksson Gizur G; Palsson Runolfur R; Indridason Olafur S OS;
Affiliation : Department of Physiology, School of Health Sciences, University of Iceland, Reykjavik, Iceland.
Journal : Europace   (2010)
Related Links: Pubmed | Publisher website
Comprehensive risk reduction in patients with atrial fibrillation: emerging diagnostic and therapeutic options—a report from the 3rd Atrial Fibrillation Competence NETwork/European Heart Rhythm Association consensus conference
Authors :
Affiliation : Tel: +49 251 8345185; fax: +49 251 8345185, Email: kirchhp@uni-muenster.de
Journal : N/A   (2011)
Related Links: Pubmed | Publisher website
Does treatment with n-3 polyunsaturated fatty acids prevent atrial fibrillation after open heart surgery?
Authors : Heidarsdottir R; Arnar DO; Skuladottir GV; Torfason B; Edvardsson V; Gottskalksson G; Palsson R;
Affiliation : Division of Nephrology, Landspitali University Hospital, Office 14-F, Hringbraut, 101 Reykjavik, Iceland. Tel: +354 543 1000; fax: +354 543 4806. E-mail address: olasi@landspitali.is
Journal : EP Europace   (2010)
Related Links: Pubmed | Publisher website
Pharmacological cardioversion of atrial fibrillation—a double-blind, randomized, placebo-controlled, multicentre, dose-escalation study of AZD1305 given intravenously
Authors : Rónaszéki A; Alings M; Egstrup K; Gaciong Z; Hranai M; Király C; Sereg M; Figatowski W; Bondarov P; Johansson S; Frison L; Edvardsson N;
Affiliation : Department of Cardiology, Péterfy Hospital, Budapest, Hungary. Tel: +46 31 776 1000; fax: +46 31 776 3737 Email: anders.r.berggren@astrazeneca.com
Journal : Eurpopace   (2011)
Related Links: Pubmed | Publisher website
Comprehensive risk reduction in patients with atrial fibrillation: emerging diagnostic and therapeutic options--a report from the 3rd Atrial Fibrillation Competence NETwork/European Heart Rhythm Association consensus conference.
Authors : Kirchhof P; Lip GY; Van Gelder IC; Bax J; Hylek E; Kaab S; Schotten U; Wegscheider K; Boriani G; Brandes A; Ezekowitz M; Diener H; Haegeli L; Heidbuchel H; Lane D; Mont L; Willems S; Dorian P; Aunes-Jansson M; Blomstrom-Lundqvist C; Borentain M; Breitenstein S; Brueckmann M; Cater N; Clemens A; Dobrev D; Dubner S; Edvardsson NG; Friberg L; Goette A; Gulizia M; Hatala R; Horwood J; Szumowski L; Kappenberger L; Kautzner J; Leute A; Lobban T; Meyer R; Millerhagen J; Morgan J; Muenzel F; Nabauer M; Baertels C; Oeff M; Paar D; Polifka J; Ravens U; Rosin L; Stegink W; Steinbeck G; Vardas P; Vincent A; Walter M; Breithardt G;
Affiliation : University Hospital Münster, Münster, Germany. Corresponding author. Tel: +49 251 8345185; fax: +49 251 8345185, Email: kirchhp@uni-muenster.de
Journal : Europace   (2011)
Related Links: Pubmed | Publisher website
Pharmacological cardioversion of atrial fibrillation—a double-blind, randomized, placebo-controlled, multicentre, dose-escalation study of AZD1305 given intravenously
Authors : Rónaszéki A; Alings M; Egstrup K; Gaciong Z; Hranai M; Király C; Sereg M; Figatowski W; Bondarov P; Johansson S; Frison L; Edvardsson N;
Affiliation : Department of Cardiology, Péterfy Hospital, Budapest, Hungary. Corresponding author. Tel: +46 31 776 1000; fax: +46 31 776 3737, Email: anders.r.berggren@astrazeneca.com
Journal : EP Europace   (2011)
Related Links: Pubmed | Publisher website

Ablation Specialist

Jafib
Powered by - Jafib Team   Privacy Policy | Site Map
hits counter